
Syngene International Limited has informed the Exchange regarding a press release dated March 19, 2025, titled "Syngene concludes the acquisition of Biologics Manufacturing Facility from Emergent BioSolutions Inc.".
Filed with NSE ·

Syngene International Limited has informed the Exchange regarding a press release dated March 19, 2025, titled "Syngene concludes the acquisition of Biologics Manufacturing Facility from Emergent BioSolutions Inc.".
6ix hasn’t read this filing yet.
Syngene International Ltd. on 6ix
Follow Syngene International into a list and get an email when it puts out news.
Follow Syngene International